- Home
- SUPN vs OSW Comparison
SUPN vs OSW Comparison
Compare SUPN & OSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- OSW
- Stock Information
- Founded
- SUPN 2005
- OSW 2017
- Country
- SUPN United States
- OSW Bahamas
- Employees
- SUPN N/A
- OSW N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- OSW Hotels/Resorts
- Sector
- SUPN Health Care
- OSW Consumer Discretionary
- Exchange
- SUPN Nasdaq
- OSW Nasdaq
- Market Cap
- SUPN 2.6B
- OSW 2.3B
- IPO Year
- SUPN 2012
- OSW N/A
- Fundamental
- Price
- SUPN $44.51
- OSW $21.93
- Analyst Decision
- SUPN Buy
- OSW Strong Buy
- Analyst Count
- SUPN 2
- OSW 3
- Target Price
- SUPN $43.00
- OSW $22.67
- AVG Volume (30 Days)
- SUPN 631.6K
- OSW 476.8K
- Earning Date
- SUPN 11-03-2025
- OSW 10-29-2025
- Dividend Yield
- SUPN N/A
- OSW 0.73%
- EPS Growth
- SUPN 1411.53
- OSW 32.03
- EPS
- SUPN 1.14
- OSW 0.68
- Revenue
- SUPN $665,125,000.00
- OSW $919,258,000.00
- Revenue This Year
- SUPN $4.84
- OSW $8.52
- Revenue Next Year
- SUPN $17.69
- OSW $8.82
- P/E Ratio
- SUPN $38.46
- OSW $32.16
- Revenue Growth
- SUPN 5.55
- OSW 8.51
- 52 Week Low
- SUPN $29.16
- OSW $14.21
- 52 Week High
- SUPN $46.79
- OSW $23.28
- Technical
- Relative Strength Index (RSI)
- SUPN 52.39
- OSW 49.11
- Support Level
- SUPN N/A
- OSW $20.83
- Resistance Level
- SUPN $46.72
- OSW $22.25
- Average True Range (ATR)
- SUPN 1.00
- OSW 0.64
- MACD
- SUPN -2.10
- OSW -0.09
- Stochastic Oscillator
- SUPN 95.58
- OSW 54.55
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.